» Articles » PMID: 3088568

Intercontinental Spread of a Genetically Distinctive Complex of Clones of Neisseria Meningitidis Causing Epidemic Disease

Overview
Specialty Science
Date 1986 Jul 1
PMID 3088568
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Strains of Neisseria meningitidis responsible for an epidemic of meningococcal disease occurring in Norway since the mid-1970s and for recent increases in the incidence of disease in several other parts of Europe have been identified by multilocus enzyme electrophoresis as members of a distinctive group of 22 closely related clones (the ET-5 complex). Clones of this complex have also colonized South Africa, Chile, Cuba, and Florida, where they have been identified as the causative agents of recent outbreaks of meningococcal disease. There is strong circumstantial evidence that outbreaks of disease occurring in Miami in 1981 and 1982 were caused in large part by bacteria that reached Florida via human immigrants from Cuba.

Citing Articles

Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.

Kilian M, Husby S, Andersen J, Moldoveanu Z, Skov Sorensen U, Reinholdt J mBio. 2022; 13(3):e0055022.

PMID: 35420467 PMC: 9239265. DOI: 10.1128/mbio.00550-22.


Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis.

Caugant D, Brynildsrud O Nat Rev Microbiol. 2019; 18(2):84-96.

PMID: 31705134 DOI: 10.1038/s41579-019-0282-6.


A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.

Beernink P, Vianzon V, Lewis L, Moe G, Granoff D mBio. 2019; 10(3).

PMID: 31213564 PMC: 6581866. DOI: 10.1128/mBio.01231-19.


Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.

Krone M, Gray S, Abad R, Skoczynska A, Stefanelli P, van der Ende A Euro Surveill. 2019; 24(14).

PMID: 30968827 PMC: 6462787. DOI: 10.2807/1560-7917.ES.2019.24.14.1800245.


The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment.

Maiden M Front Immunol. 2019; 9:3151.

PMID: 30697213 PMC: 6340965. DOI: 10.3389/fimmu.2018.03151.


References
1.
Frasch C, CHAPMAN S . Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers. J Infect Dis. 1973; 127(2):149-54. DOI: 10.1093/infdis/127.2.149. View

2.
Jyssum K, Lie S . GENETIC FACTORS DETERMINING COMPETENCE IN TRANSFORMATION OF NEISSERIA MENINGITIDIS. 1. A PERMANENT LOSS OF COMPETENCE. Acta Pathol Microbiol Scand. 1965; 63:306-16. DOI: 10.1111/apm.1965.63.2.306. View

3.
Craven D, Frasch C . Serogroup identification of meningococci by a modified antiserum agar method. J Clin Microbiol. 1979; 9(4):547-8. PMC: 273073. DOI: 10.1128/jcm.9.4.547-548.1979. View

4.
Poolman J, Hopman C, Zanen H . Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers. J Gen Microbiol. 1980; 116(2):465-73. DOI: 10.1099/00221287-116-2-465. View

5.
Zollinger W, Mandrell R . Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins. Infect Immun. 1980; 28(2):451-8. PMC: 550956. DOI: 10.1128/iai.28.2.451-458.1980. View